Aster DM Healthcare to hold Unsecured Trade Creditors Meeting on March 10, 2026 for Amalgamation Scheme
Aster DM Healthcare Limited will hold a meeting for Unsecured Trade Creditors on March 10, 2026, to approve the amalgamation scheme with Quality Care India Limited. Remote e-voting is available from March 6 to March 9, 2026. The cut-off date for voting eligibility is October 31, 2025.
The amalgamation process is a significant corporate action that could have a material impact on the company's structure and future operations. The outcome of the creditors' meeting is crucial for the progression of this scheme.
The announcement is a procedural update regarding a scheme of amalgamation and does not contain financial results or strategic decisions that would inherently be positive or negative.
Aster DM Healthcare Limited has announced a meeting of its Unsecured Trade Creditors on Tuesday, March 10, 2026, at 02:00 p.m. IST. This meeting, convened as per the directions of the Hon’ble National Company Law Tribunal (NCLT), Hyderabad Bench, is to consider and approve the Scheme of Amalgamation between Aster DM Healthcare Limited and Quality Care India Limited, along with their respective shareholders and creditors. The meeting will be conducted through Video Conferencing (VC) / Other Audio Visual Means (OAVM).
Remote e-voting for the Unsecured Trade Creditors will commence on Friday, March 6, 2026, at 9:00 a.m. IST and conclude on Monday, March 9, 2026, at 5:00 p.m. IST. The cut-off date for determining eligibility for remote e-voting and voting at the meeting is Friday, October 31, 2025. Voting rights will be in proportion to the outstanding amount due as of the cut-off date. The notice of the meeting, along with explanatory statements and annexures, is being dispatched to the Unsecured Trade Creditors. National Securities Depository Limited (NSDL) is providing the remote e-voting facility. The scheme, if approved by the creditors, will be subject to further sanction by the NCLT and other regulatory authorities.
What to do with a filing like this
Aster DM Healthcare Limited filed this with the NSE as a statutory disclosure, categorised under amalgamation. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Aster DM Healthcare Limited. Read the original for the full detail.